Sign In
Buy WST
$316.31
+4.14 (+1.33%)
At Close: Jun 03, 2026
West Pharma EPS Jumps 22 Percent in Q2
01:12pm, Thursday, 24'th Jul 2025
West Pharmaceutical Services (WST 20.87%), a global manufacturer of drug packaging and delivery systems for the pharmaceutical and healthcare industries, reported Q2 2025 earnings on July 24, 2025. Th
WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit
11:50am, Thursday, 24'th Jul 2025
West Pharmaceutical's second-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars
10:38am, Thursday, 24'th Jul 2025
West Pharmaceutical Services, Inc. WST shares are surging Thursday after the injectable pharmaceutical packaging and delivery systems company delivered a robust beat on its second-quarter 2025 earning
West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings
10:04am, Thursday, 24'th Jul 2025
West Pharmaceutical stock catapulted Thursday after the medical player blew second-quarter expectations out of the water.
West Pharmaceutical Services (WST) Surpasses Q2 Earnings and Revenue Estimates
08:11am, Thursday, 24'th Jul 2025
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.52 per share a year ago
West Pharma raises annual profit forecast on strong demand for its drug components
08:02am, Thursday, 24'th Jul 2025
Medical equipment maker West Pharmaceutical raised its annual profit forecast on Thursday, after topping second-quarter estimates on robust demand for its components used in GLP-1 weight-loss and diab
West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance
06:00am, Thursday, 24'th Jul 2025
- Conference Call Scheduled for 8 a.m. EDT Today - EXTON, Pa.
WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up?
01:16pm, Tuesday, 22'nd Jul 2025
West Pharmaceutical targets steady Q2 growth as high-value GLP-1 and SmartDose demand drives segment momentum.
West Welcomes Robert McMahon as Incoming Chief Financial Officer
06:00am, Monday, 21'st Jul 2025
EXTON, Pa. , July 21, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the appointment
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against West Pharmaceutical Services, In
West to Host Second-Quarter 2025 Conference Call
06:00am, Tuesday, 08'th Jul 2025
EXTON, Pa. , July 8, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will rele
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST).
NEW YORK , July 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such inv
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceuticals
01:07pm, Monday, 07'th Jul 2025
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) and reminds inv
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceuticals
01:06pm, Monday, 07'th Jul 2025
NEW YORK--(BUSINESS WIRE)---- $WST #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (“West”
